Fig. 2: Real-world progression-free survival and overall survival in all patients by ERBB2 amplification status.

Kaplan–Meier survival curves comparing rwPFS and rwOS in all patients by ERBB2 amplification. rwPFS real-world progression-free survival, rwOS real-world overall survival, HR hazard ratio, CI confidence interval.